This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

H1N1 Masks Boost Firm

NEW YORK ( TheStreet) -- Alpha Pro Tech (APT - Get Report) has performed well since our initial look of the stock on Aug. 8. At the time, APT was trading at $3.50 per share.

On Oct. 27, the company reported $16.89 million in revenue for the third quarter compared with $10.22 million for the year-ago quarter. It reported 12 cents a share in earnings compared with 3 cents a year ago. The earnings beat analysts' estimates by 1 cent.

The company's fully diluted shares fell 6.51% from 24.72 million shares a year ago to 23.11 million shares in the past quarter.

Following the earnings report, the stock sustained a hard pullback from its opening price of $7.22 to a close at $5.69 the following day. However, APT has subsequently rebounded, reaching an intraday high of $6.83 on Nov. 3.

We urge interested investors to listen to the company's bullish conference call replay. Here are some of our notes and thoughts on the call.

Alpha Pro Tech is reporting exceptionally strong growth in two of its product categories: infection control and building supply.

The infection-control segment, which makes protective masks, continues to benefit from the H1N1 pandemic. The run rate of its N95 H1N1 masks is at $36 million and is at full capacity.

Alpha Pro Tech is considering the addition of new N95 manufacturing lines, each capable of contributing $9 million in annual revenue. The company speculated that the H1N1 pandemic could last two to five years, which bodes well for an acceleration of its sales momentum through at least 2010. Gross margins should also see gradual improvement as its N95 mask revenues increase.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
TSTC $0.00 0.00%
TXIC $0.02 0.00%
APT $1.99 2.58%
HPJ $1.85 0.00%
AAPL $94.01 -1.20%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs